Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$4.22 - $5.85 $84 - $117
-20 Closed
0 $0
Q1 2021

Jun 17, 2021

SELL
$6.02 - $8.06 $626 - $838
-104 Reduced 83.87%
20 $1,000
Q1 2021

Jun 08, 2021

BUY
$6.02 - $8.06 $746 - $999
124 New
124 $1,000

Others Institutions Holding KMDA

About KAMADA LTD


  • Ticker KMDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 44,800,500
  • Market Cap $264M
  • Description
  • Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...
More about KMDA
Track This Portfolio

Track Prentice Wealth Management LLC Portfolio

Follow Prentice Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prentice Wealth Management LLC with notifications on news.